dcat - Robuta Search

https://www.w3.org/TR/vocab-dcat-3/ Data Catalog Vocabulary (DCAT) - Version 3 DCAT is an RDF vocabulary designed to facilitate interoperability between data catalogs published on the Web. This document defines the schema and provides... data catalog vocabulary dcat version https://www.dcatvci.org/ DCAT Value Chain Insights Jul 3, 2025 - DCAT Value Chain Insights is an online information resource offering news and analysis on the issues impacting the business of pharmaceutical development and... value chain dcat insights https://www.w3.org/TR/vocab-dcat-2/ Data Catalog Vocabulary (DCAT) - Version 2 DCAT is an RDF vocabulary designed to facilitate interoperability between data catalogs published on the Web. This document defines the schema and provides... data catalog vocabulary dcat version https://www.dcatvci.org/top-industry-news/daiichi-sankyo-ultragenyx-in-gene-therapy-mfg-pact-worth-up-to-225-m/ Daiichi Sankyo, Ultragenyx in Gene-Therapy Mfg Pact Worth Up To $225 M - DCAT Value Chain Insights Sep 8, 2021 - Daiichi Sankyo has formed a licensing pact with Ultragenyx Pharmaceutical, a biopharmaceutical company developing drugs for rare and ultra-rare genetic... https://www.dcatvci.org/top-industry-news/novo-nordisk-invests-65-million-to-expand-us-finished-products-mfg-plant/ Novo Nordisk Invests $65 Million to Expand US Finished-Products Mfg Plant - DCAT Value Chain... Sep 8, 2021 - Novo Nordisk plans to invest $65 million to expand its finished-products manufacturing facility at its Clayton, Johnston County, North Carolina campus. This is... https://www.dcatvci.org/top-industry-news/flexion-patheon-plan-dedicated-mfg-suite/ Flexion, Patheon Plan Dedicated Mfg Suite - DCAT Value Chain Insights Sep 8, 2021 - Flexion Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, has entered into a strategic manufacturing and supply agreement with Patheon,... value chain flexion patheon plan dedicated https://www.dcatvci.org/top-industry-news/signal-genetics-miragen-to-merge-for-micro-rna-drugs/ Signal Genetics, Miragen to Merge for Micro-RNA Drugs - DCAT Value Chain Insights Sep 8, 2021 - Signal Genetics, a Carlsbad, California- based commercial-stage molecular diagnostic company, and Miragen Therapeutics, a Boulder, Colorado-based... https://docs.dataportal.se/dcat/3.0.1/en/ DCAT-AP-SE version 3.0.1 dcat ap se version https://www.dcatvci.org/top-industry-news/seattle-genetics-unum-form-646-m-cancer-pact/ Seattle Genetics, Unum Form $646 M Cancer Pact - DCAT Value Chain Insights Sep 8, 2021 - Seattle Genetics, Inc. and Unum Therapeutics have entered into a strategic collaboration and license agreement to develop and commercialize antibody-coupled... https://www.dcatvci.org/top-industry-news/sagent-nichi-iko-agree-to-merge-in-736-million-deal/ Sagent, Nichi-Iko Agree to Merge in $736 Million Deal - DCAT Value Chain Insights Sep 8, 2021 - Nichi-Iko Pharmaceutical Co., Ltd., a Japan-headquartered generic drug company, and Sagent Pharmaceuticals, Inc. have entered into a definitive merger... https://www.w3.org/events/meetings/e57dfe48-ef33-4a2c-af6f-4f6a5846df65/20230110T220000/ 10 January 2023 | DCAT subgroup | W3C The World Wide Web Consortium (W3C) is an international community where Member organizations, a full-time staff, and the public work together to develop Web... january dcat subgroup https://www.dcatvci.org/top-industry-news/novartis-acquires-admune-signs-pacts-in-immunotherapies/ Novartis Acquires Admune: Signs Pacts in Immunotherapies - DCAT Value Chain Insights Sep 8, 2021 - Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics and licensing agreements with Palobiofarma and XOMA... value chain novartis acquires signs pacts https://www.dcatvci.org/top-industry-news/evonik-brenntag-in-hydrogen-peroxide-pact-for-pharma/ Evonik, Brenntag in Hydrogen Peroxide Pact for Pharma - DCAT Value Chain Insights Sep 8, 2021 - Evonik Industries is introducing new hydrogen peroxide and peracetic acid grades for drug, medical products, and cosmetics manufacturers. As the central point... hydrogen peroxide https://www.dcatvci.org/top-industry-news/recipharm-lobsor-sign-mfg-pact/ Recipharm, Lobsor Sign Mfg Pact - DCAT Value Chain Insights Sep 8, 2021 - Recipharm, a contract development and manufacturing organization, and LobSor Pharmaceuticals, an Uppsala, Sweden-based pharmaceutical company focusing on... value chain recipharm sign mfg pact https://www.dcatvci.org/top-industry-news/gsk-files-nda-in-japan-for-respiratory-mab/ GSK Files NDA in Japan for Respiratory mAb - DCAT Value Chain Insights Sep 8, 2021 - GlaxoSmithKline (GSK) has submitted a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for mepolizumab as an add-on... in japan https://www.dcatvci.org/top-industry-news/amneal-pharmaceuticals-impax-laboratories-to-merge/ Amneal Pharmaceuticals, Impax Laboratories To Merge - DCAT Value Chain Insights Sep 8, 2021 - Amneal Pharmaceuticals, a Paterson, New Jersey-based generic-drug manufacturer, and Impax Laboratories, a Hayward, California-based specialty pharmaceutical... amneal pharmaceuticals value chain impax laboratories merge https://www.dcatvci.org/top-industry-news/valeant-to-sell-inova-rx-and-otc-business-for-930-million/ Valeant To Sell iNova Rx and OTC Business for $930 Million - DCAT Value Chain Insights Sep 8, 2021 - Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its iNova Pharmaceuticals business to a company jointly owned by funds... https://www.dcatvci.org/top-industry-news/bayer-appoints-new-head-of-consumer-healthcare-biz/ Bayer Appoints New Head of Consumer Healthcare Biz - DCAT Value Chain Insights Sep 8, 2021 - Bayer has appointed Heiko Schipper to the Board of Management of Bayer effective March 1, 2018. He will succeed Erica Mann as the head of the Consumer Health... consumer healthcare https://www.dcatvci.org/top-industry-news/capsugel-to-invest-25-mm-for-veg-capsules-mfg-expansion/ Capsugel To Invest $25 MM for Veg Capsules Mfg Expansion - DCAT Value Chain Insights Sep 8, 2021 - Capsugel plans invest more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules. The... https://www.dcatvci.org/top-industry-news/sanofi-to-create-new-standalone-api-mfg-company-in-europe/ Sanofi To Create New, Standalone API Mfg Company in Europe - DCAT Value Chain Insights Sep 8, 2021 - Sanofi plans to create a new European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (APIs). Sanofi... https://www.dcatvci.org/top-industry-news/basf-plans-pvp-expansion/ BASF Plans PVP Expansion - DCAT Value Chain Insights Sep 8, 2021 - BASF plans to invest up to EUR 56 million in the expansion of its polyvinylpyrrolidone (PVP) value chain over the next four years. PVP is a polymer that is... value chain basf plans pvp expansion https://datasets.ai/datasets/https-ttsk-dcat-sk-mikroregiony-ttsk-2024-obce-ttl dataset https-ttsk-dcat-sk-mikroregiony-ttsk-2024-obce-ttl | DataSets.ai dataset https dcat sk https://open-north.de/blog/2026-03-15_dcat_spatial/ DCAT Geometrien | Open North Es ist üblich, für DCAT Datensätze einen Raumbezug anzugeben. Die Angabe dafür ist dct:spatial. Man kann das über einen URI machen aber auch frei eine... dcat geometrien open north https://www.dcatvci.org/top-industry-news/bayer-to-acquire-asklepios-biopharmaceutical-in-4-bn-deal/ Bayer To Acquire Asklepios BioPharmaceutical in $4-Bn Deal - DCAT Value Chain Insights Sep 8, 2021 - Bayer has agreed to acquire Asklepios BioPharmaceutical (AskBio), a Research Triangle Park, North Carolina-based clinical-stage gene-therapy company, in a deal... https://www.dcatvci.org/top-industry-news/merck-kgaa-discontinues-development-of-lung-cancer-therapy-tecemotide/ Merck KGaA Discontinues Development of Lung Cancer Therapy Tecemotide - DCAT Value Chain Insights Sep 8, 2021 - Merck KGaA will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy, tecemotide, as a monotherapy in... https://www.dcatvci.org/top-industry-news/alfa-aesar-launches-new-heterogeneous-catalyst-kit/ Alfa Aesar Launches New Heterogeneous Catalyst Kit - DCAT Value Chain Insights Sep 8, 2021 - Alfa Aesar has launched a new Heterogeneous Catalyst Kit, developed by Johnson Matthey Catalysis and Chiral Technologies. The new Heterogeneous Catalyst Kit... value chain alfa launches new heterogeneous https://www.dcatvci.org/top-industry-news/genticel-gets-us-patent-for-antigen-delivery-vector/ Genticel Gets US Patent for Antigen Delivery Vector - DCAT Value Chain Insights Sep 8, 2021 - Genticel, a clinical-stage biotechnology company developing immunotherapies to prevent human papillomavirus (HPV)-induced cancers, has received a US Patent... us patent https://www.dcat.mx/product-page/carcazas Carcaza compatible con W900 | DCAT Tractopartes Carcaza compatible con W900 Terminado: Cromado Nota:Estos productos no son originales.Las marcas que aparecen son de sus propietarios y se utilizan como... compatible con dcat https://catalogador-dth.sisp.gov.br/validacao Validador DCAT-BR dcat br https://www.dcatvci.org/supplier-news/cordenpharma-investing-more-than-1-bn-to-expand-peptide-production-capacity/ CordenPharma Investing More Than $1-Bn to Expand Peptide Production Capacity - DCAT Value Chain... https://www.dcatvci.org/top-industry-news/impax-laboratories-receives-a-form-483-for-taiwan-manufacturing-facility/ Impax Laboratories Receives a Form 483 for Taiwan Manufacturing Facility - DCAT Value Chain Insights Sep 8, 2021 - Impax Laboratories has received a Form 483 with 10 inspectional observations from the US Food and Drug Administration (FDA) based on a general GMP inspection... https://dmcfinder.com/listing/discover-central-asia-tours-dcat/ Discover Central Asia Tours (DCAT) DMCFinder - Destination Management Company Jun 27, 2024 - DMCFinder - Discover Central Asia Tours (DCAT). Type: Premium DMC. Categories: DMC, Mice DMC. Regions: Kyrgyzstan. central asia tours destination management discover dcat company https://dcat.org/ Home - DCAT May 15, 2026 - The premier association for the global Bio/Pharmaceutical manufacturing value chain dcat https://www.dcatvci.org/top-industry-news/fda-posts-warning-letter-for-hospira-facility-in-italy/ FDA Posts Warning Letter for Hospira Facility in Italy - DCAT Value Chain Insights Sep 8, 2021 - The US Food and Drug Administration has posted a Warning Letter to Hospira, dated March 31, 2015, for cGMP violations for finished pharmaceuticals at the... https://www.dcatvci.org/top-industry-news/supplier-news-milliporesigma-cytiva-nanopharm/ Supplier News: MilliporeSigma, Cytiva & Nanopharm - DCAT Value Chain Insights Oct 6, 2022 - The latest from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Cytiva, Nanopharm and Schott. Biologics Mfg* MilliporeSigma Opens Biomanufacturing... supplier news value chain milliporesigma cytiva nanopharm https://www.dcatvci.org/top-industry-news/adc-bio-to-invest-in-bioconjugation-facility/ ADC Bio To Invest in Bioconjugation Facility - DCAT Value Chain Insights Sep 8, 2021 - ADC Biotechnology (ADC Bio), a St. Asaph, North Wales-headquartered contract services company for antibody drug conjugates (ADCs), is investing $11 million for... to invest value chain adc bio https://www.dcatvci.org/top-industry-news/avantor-to-increase-single-use-capacity-sharp-in-43-m-expansion/ Avantor To Increase Single-Use Capacity; Sharp in $43-M Expansion - DCAT Value Chain Insights May 4, 2022 - The latest from CDMOs, CMOs, and suppliers featuring Avantor, Sharp, Cytiva, Vetter, Rentschler Biopharma, PPD, Catalent, Bushu Pharma, and others.... https://www.dcatvci.org/top-industry-news/astellas-launches-dedicated-big-data-function/ Astellas Launches Dedicated Big Data Function - DCAT Value Chain Insights Sep 8, 2021 - Astellas Pharma Inc. has launched the Real World Informatics and Analytics (RWI) function, effective July 1, 2015. The RWI function is headquartered in... big data value chain astellas launches dedicated https://www.dcatvci.org/top-industry-news/hospira-to-voluntarily-recall-one-lot-of-lidocaine-for-particulate-matter/ Hospira to Voluntarily Recall One Lot of Lidocaine for Particulate Matter - DCAT Value Chain... Sep 8, 2021 - Hospira, Inc. will initiate a voluntary recall of one lot of Lidocaine HCI Injection, USP, 2%, 20 mg per mL, 5-mL single-Dose Vial, Preservative-Free (NDC... https://www.dcat.net/ DCAT - Development Center for Appropriate Technology development center dcat appropriate technology https://www.dcatvci.org/top-industry-news/baxter-merrimack-pharmaceuticals-sign-pact-for-pancreatic-cancer-drug/ Baxter, Merrimack Pharmaceuticals Sign Pact for Pancreatic Cancer Drug - DCAT Value Chain Insights Sep 8, 2021 - Baxter International Inc. and Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, have formed an exclusive license and collaboration agreement for... https://www.dcatvci.org/top-industry-news/abbvie-s-cancer-drug-gets-breakthrough-status/ AbbVie's Cancer Drug Gets Breakthrough Status - DCAT Value Chain Insights Sep 8, 2021 - AbbVie announced its investigational medicine venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with... cancer drug value chain abbvie gets https://www.geonovum.nl/nieuws/moet-dcat-ap-nl-30-verplicht-worden-voor-de-overheid Moet DCAT-AP-NL 3.0 verplicht worden voor de overheid? | Geonovum Op verzoek van Geonovum toetst Forum Standaardisatie of versie 3.0 van de standaard DCAT-AP-NL geschikt is om te verplichten aan de overheid. Het expertadvies... https://www.dcatvci.org/top-industry-news/supplier-news-roquette-bora-pharma-ubrigene/ Supplier News; Roquette, Bora Pharma, UBriGene - DCAT Value Chain Insights Aug 4, 2023 - The latest news from CDMOs/CMOs and suppliers featuring Roquette, Bora Pharmaceuticals, and UBriGene Biosciences. Biologics Manufacturing *UBriGene Biosciences... supplier news value chain roquette bora pharma https://www.dcatvci.org/top-industry-news/allergan-settles-claims-on-warner-chilcott-sales-marketing-practices/ Allergan Settles Claims on Warner Chilcott Sales, Marketing Practices - DCAT Value Chain Insights Sep 8, 2021 - Allergan plc reports that its indirect subsidiary, Warner Chilcott Sales (US) LLC, has reached a resolution with the federal government, as well as 50 states... https://datosgobes.github.io/DCAT-AP-ES/ DCAT-AP-ES Portal para la implementación de la NTI-RISP de acuerdo con el perfil de aplicación DCAT-AP-ES. dcat ap es https://www.dcatvci.org/top-industry-news/cytovance-biologics-completes-manufacturing-project-for-armo-biosciences/ Cytovance Biologics Completes Manufacturing Project for ARMO Biosciences - DCAT Value Chain Insights Sep 8, 2021 - Cytovance Biologics, a contract manufacturer of mammalian and microbial biologics based in Oklahoma City, announces the successful completion of GMP... https://semiceu.github.io/DCAT-AP/releases/3.0.1/CHANGELOG.html Consolidated ChangeLog | DCAT-AP This is the issue tracker for the maintenance of DCAT-AP consolidated changelog dcat ap https://www.dcatvci.org/top-industry-news/plasticell-partners-in-stem-cell-product/ Plasticell Partners in Stem-Cell Product - DCAT Value Chain Insights Sep 8, 2021 - Plasticell, a Stevenage, UK-based developer of stem-cell technologies and cell therapies, has partnered with Anthony Nolan, a research organization for blood... stem cell value chain partners product dcat https://biodivportal.gfbio.org/ontologies/DCAT?p=notes DCAT | Notes | NFDI4Biodiversity BiodivPortal dcat notes https://datalandsbyen.norge.no/topic/372/eu-tar-i-mot-innspel-til-ny-versjon-av-dcat-ap EU tar i mot innspel til ny versjon av DCAT-AP | Datalandsbyen Jun 16, 2024 - Semic Support Centre i EU har publisert ein ny versjon av "DCAT Application Profile for data portals in Europe" (DCAT-AP 3.0.0), og ber no om tilbakemeldinga... https://www.dcatvci.org/top-industry-news/novo-nordisk-invests-143-million-in-diabetes-center/ Novo Nordisk Invests $143 Million in Diabetes Center - DCAT Value Chain Insights Sep 8, 2021 - Novo Nordisk has formed a research collaboration with the University of Oxford in the UK for the development of Type 2 diabetes under which Novo Nordisk will... novo nordisk https://www.dcatvci.org/top-industry-news/takeda-reports-moderate-revenue-growth/ Takeda Reports Moderate Revenue Growth - DCAT Value Chain Insights Sep 8, 2021 - Following taking on the additional role of chief executive officer (CEO) in April 2015, Christophe Weber, president and CEO of Takeda, reported moderate... revenue growth value chain takeda reports moderate https://www.dcatvci.org/top-industry-news/sagent-pharmaceuticals-acquires-omega-laboratories/ Sagent Pharmaceuticals Acquires Omega Laboratories - DCAT Value Chain Insights Sep 8, 2021 - Sagent Pharmaceuticals, Inc., a provider of specialty pharmaceutical products with an emphasis on the injectable market, has acquired Omega Laboratories... sagent pharmaceuticals value chain acquires omega laboratories https://www.dcatvci.org/top-industry-news/catalent-completes-biomfg-expansions-aceto-acquires-a-c/ Catalent Completes Biomfg Expansions; Aceto Acquires A&C - DCAT Value Chain Insights Sep 8, 2021 - The latest from CDMOs, CMOs, and suppliers featuring Catalent, Lonza, Aceto, Abzena, and Ascendia Pharmaceuticals. Chemicals/Chemical API Manufacturing Aceto... https://www.dcatvci.org/top-industry-news/jj-completes-14-6-bn-acquisition-of-intra-cellular-therapeutics/ J&J Completes $14.6-Bn Acquisition of Intra-Cellular Therapeutics - DCAT Value Chain Insights https://www.dcatvci.org/top-industry-news/astrazeneca-receives-eu-approval-for-moventig/ AstraZeneca Receives EU Approval for Moventig - DCAT Value Chain Insights Sep 8, 2021 - AstraZeneca has received marketing authorization by the European Commission (EC) for Moventig (naloxegol) has for the treatment of opioid-induced constipation... value chain astrazeneca receives eu approval https://www.dcatvci.org/top-industry-news/bi-expands-immuno-oncology-pact/ BI Expands Immuno-Oncology Pact - DCAT Value Chain Insights Sep 8, 2021 - Boehringer Ingelheim (BI) and Sarah Cannon Research Institute, the research arm of Nashville, Tennessee-based Sarah Cannon, a global cancer institute of the... immuno oncology value chain bi expands pact https://www.dcatvci.org/top-industry-news/private-equity-firm-backs-purchase-of-lyophilization-cdmo-lsne/ Private Equity Firm Backs Purchase of Lyophilization CDMO LSNE - DCAT Value Chain Insights Sep 8, 2021 - An undisclosed company backed by Permira, a London-headquartered private equity firm, has agreed to acquire Lyophilization Services of New England (LSNE), a... https://www.dcatvci.org/features/how-will-biotech-venture-capital-fare-in-2016/ How Will Biotech Venture Capital Fare in 2016? - DCAT Value Chain Insights Sep 13, 2021 - A recent analysis, the MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association based on data from Thomson Reuters, showed that... venture capital https://www.dcatvci.org/top-industry-news/torrent-expands-recall-of-losartan/ Torrent Expands Recall of Losartan - DCAT Value Chain Insights Sep 8, 2021 - Torrent Pharmaceuticals, an India-based pharmaceutical company, is expanding its voluntary recall from two lots of losartan potassium tablets USP to a total of... value chain torrent expands recall losartan https://www.dcatvci.org/top-industry-news/lilly-announces-changes-in-commercial-organization-and-leadership/ Lilly Announces Changes in Commercial Organization and Leadership - DCAT Value Chain Insights Sep 8, 2021 - Eli Lilly and Company has made a series of changes to its commercial organization and leadership structure. The moves come as David A. Ricks assumed the role... organization and leadership https://open-north.de/blog/2025-08-17_organisationen/ Organisationen in DCAT-AP.de | Open North Wie viele öffentliche Organisationen aus Deutschland liefern eigentlich offene Daten? Mit einer SPARQL-Abfrage bei GovData sollte das schnell beantwortet sein.... organisationen dcat ap de open https://www.dcatvci.org/features/changing-the-rules-of-the-game-for-apis-in-the-eu/ Changing the Rules of the Game for APIs in the EU - DCAT Value Chain Insights Sep 13, 2021 - Innovator and generic-drug companies are squaring off as European Union (EU) authorities draw closer to adopting an export manufacturing waiver for... changing the rules https://www.dcatvci.org/top-industry-news/recipharm-plans-to-increase-staffing-for-brexit/ Recipharm Plans To Increase Staffing In Preparation for Brexit - DCAT Value Chain Insights Sep 8, 2021 - Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has established a dedicated task force to manage the potential impact... https://www.dcatvci.org/top-industry-news/j-j-completes-acquisition-of-alios-biopharma/ J&J Completes Acquisition of Alios BioPharma - DCAT Value Chain Insights value chain j completes acquisition alios https://www.dcatvci.org/top-industry-news/alvotech-finesse-solutions-partner-in-biomanufacturing/ Alvotech, Finesse Solutions Partner in Biomanufacturing - DCAT Value Chain Insights Sep 8, 2021 - Alvotech, an independent sister company of the pharmaceutical company Alvogen, and Finesse Solutions Inc., a provider of turnkey single-use upstream... solutions partner value chain alvotech finesse biomanufacturing https://www.dcatvci.org/top-industry-news/takeda-partners-for-gastric-drug-devices/ Takeda Partners for Gastric Drug Devices - DCAT Value Chain Insights Sep 8, 2021 - Takeda Pharmaceutical and BioSurfaces, an Ashland, Massachusetts-based biomedical research company, have entered into an agreement to initiate a research... value chain takeda partners gastric drug https://www.dcatvci.org/top-industry-news/pharmaceutical-inspection-co-operation-scheme-sets-2017-2019-goals/ Pharmaceutical Inspection Co-Operation Scheme Sets 2017-2019 Goals - DCAT Value Chain Insights Sep 8, 2021 - The Pharmaceutical Inspection Co-operation Scheme (PIC/S), a non-binding, informal co-operative arrangement between regulatory authorities in the field of good... https://www.dcatvci.org/top-industry-news/fda-approves-novartis-cancer-drug-farydak/ FDA Approves Novartis' Cancer Drug Farydak - DCAT Value Chain Insights Sep 8, 2021 - Novartis reports that the US Food and Drug Administration (FDA) has approved Farydak (panobinostat) capsules in combination with bortezomib and dexamethasone... cancer drug value chain fda novartis dcat https://www.dcatvci.org/top-industry-news/aurobindo-cited-by-fda-in-inspection-of-formulation-plant/ Aurobindo Cited by FDA in Inspection of Formulation Plant - DCAT Value Chain Insights Sep 8, 2021 - Aurobindo, a Hyderabad, India-headquartered generics and active pharmaceutical ingredients manufacturer, has received a Form 483 report with six observations... https://www.dcatvci.org/top-industry-news/astrazeneca-divests-angina-drug-to-china-medical-system-holdings/ AstraZeneca Divests Angina Drug to China Medical System Holdings - DCAT Value Chain Insights Sep 8, 2021 - AstraZeneca has completed the divestment of the global rights to Imdur, outside the US, to China Medical System Holdings Ltd and its associated company, Tibet... https://www.dcatvci.org/top-industry-news/pfizer-labcentral-to-open-new-shared-facility/ Pfizer, LabCentral to Open New Shared Facility - DCAT Value Chain Insights Sep 8, 2021 - Pfizer and LabCentral, a Cambridge, Massachusetts-headquartered shared laboratory space for life-sciences and biotech start-ups, plan to open a new LabCentral... value chain pfizer open new https://www.geonovum.nl/nieuws/metadatamodel-dcat-ap-nl-v30-vastgesteld Metadatamodel DCAT-AP-NL v.3.0 vastgesteld | Geonovum In december 2024 is DCAT-AP-NL v.3.0 vastgesteld door de Programmeringsra dcat ap nl v https://www.dcatvci.org/top-industry-news/takeda-partners-in-adcs/ Takeda Partners in ADCs - DCAT Value Chain Insights Sep 8, 2021 - Takeda Pharmaceutical has entered into a research licensing agreement with LegoChem Biosciences (LCB), a biopharmaceutical company based in Daejeon, South... value chain takeda partners adcs dcat https://www.dcatvci.org/top-industry-news/astellas-janssen-end-pact-for-jak-inhibitor/ Astellas, Janssen End Pact for JAK Inhibitor - DCAT Value Chain Insights Sep 8, 2021 - Astellas Pharma Inc. reports that its license agreement with Janssen Biotech, Inc. to develop and commercialize ASP015K, Astellas' oral Janus Kinase (JAK)... jak inhibitor value chain astellas janssen end https://www.dcatvci.org/top-industry-news/abbvie-receives-fda-approval-for-additional-indication-of-humira/ AbbVie Receives FDA Approval for Additional Indication of Humira - DCAT Value Chain Insights Sep 8, 2021 - AbbVie has received US Food and Drug Administration (FDA) approval for another indication for Humira (adalimumab) for reducing signs and symptoms, and... https://www.dcatvci.org/top-industry-news/alexion-plans-new-515-m-biologics-mfg-in-ireland/ Alexion Plans New $515 M Biologics Mfg in Ireland - DCAT Value Chain Insights Sep 8, 2021 - To support production of its lead commercial product, Soloris (eculizumab), Alexion Pharmaceuticals, a specialty pharmaceutical company focusing on developing... https://www.dcatvci.org/top-industry-news/batavia-biosciences-gates-foundation-partner-for-manufacturing-rotavirus-vaccine/ Batavia Biosciences, Gates Foundation Partner for Manufacturing Rotavirus Vaccine - DCAT Value... gates foundation for manufacturing rotavirus vaccine batavia biosciences https://www.dcatvci.org/top-industry-news/lupin-cited-by-fda-for-gmp-violations/ Lupin Cited by FDA for GMP Violations - DCAT Value Chain Insights Sep 8, 2021 - Lupin, a Mumbai, India-headquartered generic pharmaceutical company, has received a Form 483 from the US Food and Drug Administration (FDA) citing three... cited by value chain lupin fda https://www.dcatvci.org/top-industry-news/biotech-briefs-newsoara-angitia-biomica-more/ Biotech Briefs: Newsoara, Angitia, Biomica & More - DCAT Value Chain Insights Feb 6, 2026 - The latest from small and Emerging Pharma companies featuring Newsoara, vTv Therapeutics, Angitia Biopharmaceuticals, Biomice, Lishan Biopharmaceuticals and... value chain biotech briefs dcat insights https://www.dcatvci.org/features/executives-outline-expansion-plans-at-the-dcat-member-company-announcement-forum/ Executives Outline Expansion Plans at the DCAT Member Company Announcement Forum - DCAT Value Chain... Apr 11, 2022 - CEOs and senior executives from DCAT Member Companies provided the latest major news from their companies across the bio/pharmaceutical manufacturing value...